6PC8
E. coli 50S ribosome bound to compound 40q
6PC8 の概要
エントリーDOI | 10.2210/pdb6pc8/pdb |
EMDBエントリー | 20299 |
分子名称 | 23S ribosomal RNA, 5S ribosomal RNA, 50S ribosomal protein L2, ... (8 entities in total) |
機能のキーワード | e. coli ribosome, streptogramin a analog, antibiotics, ribosome |
由来する生物種 | Escherichia coli 詳細 |
タンパク質・核酸の鎖数 | 7 |
化学式量合計 | 1085808.52 |
構造登録者 | Pellegrino, J.,Lee, D.J.,Fraser, J.S.,Seiple, I.B. (登録日: 2019-06-16, 公開日: 2020-06-17, 最終更新日: 2020-10-07) |
主引用文献 | Li, Q.,Pellegrino, J.,Lee, D.J.,Tran, A.A.,Chaires, H.A.,Wang, R.,Park, J.E.,Ji, K.,Chow, D.,Zhang, N.,Brilot, A.F.,Biel, J.T.,van Zundert, G.,Borrelli, K.,Shinabarger, D.,Wolfe, C.,Murray, B.,Jacobson, M.P.,Muhle, E.,Chesneau, O.,Fraser, J.S.,Seiple, I.B. Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature, 586:145-150, 2020 Cited by PubMed Abstract: Natural products serve as chemical blueprints for most antibiotics in clinical use. The evolutionary process by which these molecules arise is inherently accompanied by the co-evolution of resistance mechanisms that shorten the clinical lifetime of any given class of antibiotics. Virginiamycin acetyltransferase (Vat) enzymes are resistance proteins that provide protection against streptogramins, potent antibiotics against Gram-positive bacteria that inhibit the bacterial ribosome. Owing to the challenge of selectively modifying the chemically complex, 23-membered macrocyclic scaffold of group A streptogramins, analogues that overcome the resistance conferred by Vat enzymes have not been previously developed. Here we report the design, synthesis, and antibacterial evaluation of group A streptogramin antibiotics with extensive structural variability. Using cryo-electron microscopy and forcefield-based refinement, we characterize the binding of eight analogues to the bacterial ribosome at high resolution, revealing binding interactions that extend into the peptidyl tRNA-binding site and towards synergistic binders that occupy the nascent peptide exit tunnel. One of these analogues has excellent activity against several streptogramin-resistant strains of Staphylococcus aureus, exhibits decreased rates of acetylation in vitro, and is effective at lowering bacterial load in a mouse model of infection. Our results demonstrate that the combination of rational design and modular chemical synthesis can revitalize classes of antibiotics that are limited by naturally arising resistance mechanisms. PubMed: 32968273DOI: 10.1038/s41586-020-2761-3 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (2.9 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード